{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T03:31:29Z","timestamp":1768447889527,"version":"3.49.0"},"reference-count":69,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:p>Perinatal depression is associated with serious risks for the mother, baby, and family. When considering treating perinatal depression with a drug indicated for the treatment of depression, the major concerns are whether the drug increases the risks of teratogenicity, pregnancy complications, poor neonatal adaptation, or neurodevelopmental disorders. Although different studies have produced different results, the majority have not shown increases in risk for selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, tricyclic antidepressants, or the noradrenergic\/dopaminergic drug bupropion. In this review we will discuss the reproductive safety data for these medications as well as monoamine oxidase inhibitors and benzodiazepines.<\/jats:p>","DOI":"10.1097\/grf.0000000000000365","type":"journal-article","created":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T14:09:35Z","timestamp":1521641375000},"page":"544-561","source":"Crossref","is-referenced-by-count":24,"title":["Pharmacotherapy for Perinatal Depression"],"prefix":"10.1097","volume":"61","author":[{"given":"SHARI I.","family":"LUSSKIN","sequence":"first","affiliation":[{"name":"Departments of Psychiatry, Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SABRINA J.","family":"KHAN","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, New York University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CARRIE","family":"ERNST","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Zucker School of Medicine at Hofstra\/Northwell, Hempstead, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SALLY","family":"HABIB","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, New York University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MADELEINE E.","family":"FERSH","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Icahn Medical School at Mount Sinai, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ELIZABETH S.","family":"ALBERTINI","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Zucker School of Medicine at Hofstra\/Northwell, Hempstead, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230911","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jad.2015.11.014","article-title":"Identifying the women at risk of antenatal anxiety and depression: a systematic review","volume":"191","author":"Biaggi","year":"2016","journal-title":"J Affect Disord"},{"key":"R2-20230911","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1089\/jwh.2014.5150","article-title":"Perinatal generalized anxiety disorder: assessment and treatment","volume":"24","author":"Misri","year":"2015","journal-title":"J Womens Health (Larchmt)"},{"key":"R3-20230911","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.4088\/JCP.v67n0818","article-title":"Anxiety disorders during pregnancy and the postpartum period: a systematic review","volume":"67","author":"Ross","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R4-20230911","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/070674370705200802","article-title":"Perinatal depression: hiding in plain sight","volume":"52","author":"Lusskin","year":"2007","journal-title":"Can J Psychiatry"},{"key":"R6-20230911","first-page":"1268","article-title":"American College of Obstetricians and Gynecologists. Screening for perinatal depression","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R7-20230911","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/jama.2015.18392","article-title":"Screening for depression in adults: US Preventive Services Task Force recommendation statement","volume":"315","author":"Siu","year":"2016","journal-title":"JAMA"},{"key":"R8-20230911","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.4088\/JCP.12m07856","article-title":"Sensitivity and specificity of the Mood Disorder Questionnaire as a screening tool for bipolar disorder during pregnancy and the postpartum period","volume":"73","author":"Frey","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"R9-20230911","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/YCT.0000000000000297","article-title":"Pregnancy and electroconvulsive therapy: a multidisciplinary approach","volume":"32","author":"Ray-Griffith","year":"2016","journal-title":"J Ect"},{"key":"R10-20230911","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/15622975.2016.1193626","article-title":"Neuroscience-based nomenclature (NbN): a call for action","volume":"17","author":"Zohar","year":"2016","journal-title":"World J Biol Psychiatry"},{"key":"R11-20230911","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11920-015-0658-x","article-title":"Bipolar disorder in pregnancy and postpartum: principles of management","volume":"18","author":"Khan","year":"2016","journal-title":"Curr Psychiatry Rep"},{"key":"R12-20230911","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJMsa1506575","article-title":"Declines in unintended pregnancy in the United States, 2008-2011","volume":"374","author":"Finer","year":"2016","journal-title":"N Engl J Med"},{"key":"R13-20230911","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/0091270010373928","article-title":"Patterns of antidepressant medication use among pregnant women in a United States population","volume":"51","author":"Alwan","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"R15-20230911","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4088\/JCP.v69n0419","article-title":"Changes in antidepressant metabolism and dosing across pregnancy and early postpartum","volume":"69","author":"Sit","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R16-20230911","doi-asserted-by":"crossref","first-page":"e0181082","DOI":"10.1371\/journal.pone.0181082","article-title":"Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: changes in drug disposition","volume":"12","author":"Westin","year":"2017","journal-title":"PLoS One"},{"key":"R17-20230911","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00737-015-0499-y","article-title":"Sertraline and breastfeeding: review and meta-analysis","volume":"18","author":"Pinheiro","year":"2015","journal-title":"Arch Womens Ment Health"},{"key":"R19-20230911","doi-asserted-by":"crossref","first-page":"e001148","DOI":"10.1136\/bmjopen-2012-001148","article-title":"Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study","volume":"2","author":"Jimenez-Solem","year":"2012","journal-title":"BMJ Open"},{"key":"R20-20230911","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1056\/NEJMoa066584","article-title":"Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects","volume":"356","author":"Alwan","year":"2007","journal-title":"N Engl J Med"},{"key":"R21-20230911","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1056\/NEJMoa067407","article-title":"First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects","volume":"356","author":"Louik","year":"2007","journal-title":"N Engl J Med"},{"key":"R22-20230911","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/AOG.0b013e318220edcc","article-title":"Selective serotonin reuptake inhibitors and risk for major congenital anomalies","volume":"118","author":"Malm","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R23-20230911","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMoa1312828","article-title":"Antidepressant use in pregnancy and the risk of cardiac defects","volume":"370","author":"Huybrechts","year":"2014","journal-title":"N Engl J Med"},{"key":"R24-20230911","doi-asserted-by":"crossref","first-page":"e013372","DOI":"10.1136\/bmjopen-2016-013372","article-title":"Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort","volume":"7","author":"Berard","year":"2017","journal-title":"BMJ Open"},{"key":"R25-20230911","doi-asserted-by":"crossref","first-page":"h1798","DOI":"10.1136\/bmj.h1798","article-title":"Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design","volume":"350","author":"Furu","year":"2015","journal-title":"BMJ"},{"key":"R28-20230911","first-page":"1001","article-title":"ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation","volume":"111","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R29-20230911","doi-asserted-by":"crossref","first-page":"e100996","DOI":"10.1371\/journal.pone.0100996","article-title":"First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a United Kingdom population-based cohort study","volume":"9","author":"Ban","year":"2014","journal-title":"PLoS One"},{"key":"R30-20230911","doi-asserted-by":"crossref","first-page":"e0165122","DOI":"10.1371\/journal.pone.0165122","article-title":"Selective serotonin reuptake inhibitor (SSRI) antidepressants in pregnancy and congenital anomalies: analysis of linked databases in Wales, Norway and Funen, Denmark","volume":"11","author":"Jordan","year":"2016","journal-title":"PLoS One"},{"key":"R31-20230911","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/bcp.13194","article-title":"SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn","volume":"83","author":"Berard","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"R34-20230911","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jama.2012.153812","article-title":"Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality","volume":"309","author":"Stephansson","year":"2013","journal-title":"JAMA"},{"key":"R35-20230911","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/EDE.0b013e31829e0aaa","article-title":"Antidepressant use and risk for preeclampsia","volume":"24","author":"Palmsten","year":"2013","journal-title":"Epidemiology"},{"key":"R36-20230911","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/pds.4286","article-title":"Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: a study from The Norwegian Mother and Child Cohort Study","volume":"26","author":"Lupattelli","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R37-20230911","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1001\/jamapsychiatry.2013.684","article-title":"Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis","volume":"70","author":"Ross","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"R38-20230911","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/1471-0528.14144","article-title":"Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis","volume":"123","author":"Eke","year":"2016","journal-title":"BJOG"},{"key":"R39-20230911","doi-asserted-by":"crossref","first-page":"e92778","DOI":"10.1371\/journal.pone.0092778","article-title":"Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis","volume":"9","author":"Huybrechts","year":"2014","journal-title":"PLoS One"},{"key":"R40-20230911","doi-asserted-by":"crossref","first-page":"f4877","DOI":"10.1136\/bmj.f4877","article-title":"Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States","volume":"347","author":"Palmsten","year":"2013","journal-title":"BMJ"},{"key":"R41-20230911","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1001\/jama.293.19.2372","article-title":"Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications","volume":"293","author":"Moses-Kolko","year":"2005","journal-title":"JAMA"},{"key":"R42-20230911","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1176\/appi.ajp.2015.14080989","article-title":"The roles of maternal depression, serotonin reuptake inhibitor treatment, and concomitant benzodiazepine use on infant neurobehavioral functioning over the first postnatal month","volume":"173","author":"Salisbury","year":"2016","journal-title":"Am J Psychiatry"},{"key":"R43-20230911","doi-asserted-by":"crossref","first-page":"605","DOI":"10.4088\/JCP.16m11044","article-title":"Neonatal discontinuation syndrome in serotonergic antidepressant-exposed neonates","volume":"78","author":"Yang","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"R44-20230911","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4088\/JCP.v65n0214","article-title":"Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure","volume":"65","author":"Oberlander","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R46-20230911","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1600-0447.2009.01490.x","article-title":"A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health","volume":"121","author":"Warburton","year":"2010","journal-title":"Acta Psychiatr Scand"},{"key":"R47-20230911","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMoa052744","article-title":"Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn","volume":"354","author":"Chambers","year":"2006","journal-title":"N Engl J Med"},{"key":"R50-20230911","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/pds.1570","article-title":"Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn","volume":"17","author":"Kallen","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R51-20230911","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/pds.1710","article-title":"Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn","volume":"18","author":"Andrade","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R52-20230911","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4065\/84.1.23","article-title":"Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy","volume":"84","author":"Wichman","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"R53-20230911","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-0030-1262507","article-title":"Persistent pulmonary hypertension of the newborn is associated with mode of delivery and not with maternal use of selective serotonin reuptake inhibitors","volume":"28","author":"Wilson","year":"2011","journal-title":"Am J Perinatol"},{"key":"R54-20230911","doi-asserted-by":"crossref","first-page":"d8012","DOI":"10.1136\/bmj.d8012","article-title":"Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries","volume":"344","author":"Kieler","year":"2012","journal-title":"BMJ"},{"key":"R55-20230911","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1001\/jama.2015.5605","article-title":"Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn","volume":"313","author":"Huybrechts","year":"2015","journal-title":"JAMA"},{"key":"R56-20230911","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1176\/ajp.2006.163.6.1026","article-title":"Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications","volume":"163","author":"Misri","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R57-20230911","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1001\/archpedi.161.1.22","article-title":"Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy","volume":"161","author":"Oberlander","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R58-20230911","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881116665335","article-title":"Prenatal exposure to selective serotonin reuptake inhibitors and non-verbal cognitive functioning in childhood","volume":"31","author":"El Marroun","year":"2017","journal-title":"J Psychopharmacol"},{"key":"R59-20230911","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jamapsychiatry.2016.2594","article-title":"Association of selective serotonin reuptake inhibitor exposure during pregnancy with speech, scholastic, and motor disorders in offspring","volume":"73","author":"Brown","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"R60-20230911","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrg.2017.4","article-title":"Autism genetics: opportunities and challenges for clinical translation","volume":"18","author":"Vorstman","year":"2017","journal-title":"Nat Rev Genet"},{"key":"R61-20230911","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archgenpsychiatry.2011.73","article-title":"Antidepressant use during pregnancy and childhood autism spectrum disorders","volume":"68","author":"Croen","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"R62-20230911","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1017\/S0033291717001301","article-title":"Autism risk following antidepressant medication during pregnancy","volume":"47","author":"Viktorin","year":"2017","journal-title":"Psychol Med"},{"key":"R63-20230911","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jama.2017.3413","article-title":"Associations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit\/hyperactivity disorder in offspring","volume":"317","author":"Sujan","year":"2017","journal-title":"JAMA"},{"key":"R64-20230911","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1001\/jama.2017.3415","article-title":"Association between serotonergic antidepressant use during pregnancy and autism spectrum disorder in children","volume":"317","author":"Brown","year":"2017","journal-title":"JAMA"},{"key":"R65-20230911","doi-asserted-by":"crossref","first-page":"j2811","DOI":"10.1136\/bmj.j2811","article-title":"Antidepressants during pregnancy and autism in offspring: population based cohort study","volume":"358","author":"Rai","year":"2017","journal-title":"BMJ"},{"key":"R66-20230911","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/jamapsychiatry.2017.1727","article-title":"Association of antidepressant medication use during pregnancy with intellectual disability in offspring","volume":"74","author":"Viktorin","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"R67-20230911","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/bcpt.12497","article-title":"First-trimester pregnancy exposure to venlafaxine or duloxetine and risk of major congenital malformations: a systematic review","volume":"118","author":"Lassen","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R68-20230911","doi-asserted-by":"crossref","first-page":"e72095","DOI":"10.1371\/journal.pone.0072095","article-title":"Prenatal antidepressant exposure and risk of spontaneous abortion\u2014a population-based study","volume":"8","author":"Kjaersgaard","year":"2013","journal-title":"PLoS One"},{"key":"R69-20230911","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/aje\/kwr394","article-title":"Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants?","volume":"175","author":"Palmsten","year":"2012","journal-title":"Am J Epidemiol"},{"key":"R70-20230911","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.4088\/JCP.15m10506","article-title":"Prenatal psychostimulant and antidepressant exposure and risk of hypertensive disorders of pregnancy","volume":"77","author":"Newport","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"R71-20230911","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ejpn.2016.11.003","article-title":"Neonatal venlafaxine discontinuation syndrome: a mini-review","volume":"21","author":"Holland","year":"2017","journal-title":"Eur J Paediatr Neurol"},{"key":"R72-20230911","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1176\/appi.ajp.2012.11111721","article-title":"Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression","volume":"169","author":"Nulman","year":"2012","journal-title":"Am J Psychiatry"},{"key":"R73-20230911","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1017\/S0033291709992194","article-title":"Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data","volume":"40","author":"Reis","year":"2010","journal-title":"Psychol Med"},{"key":"R74-20230911","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1176\/appi.ajp.159.11.1889","article-title":"Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study","volume":"159","author":"Nulman","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R75-20230911","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/pds.3661","article-title":"First-trimester exposure to bupropion and risk of cardiac malformations","volume":"23","author":"Louik","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R76-20230911","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/DBP.0b013e3181e5ac93","article-title":"Use of antidepressants during pregnancy and risk of attention-deficit\/hyperactivity disorder in the offspring","volume":"31","author":"Figueroa","year":"2010","journal-title":"J Dev Behav Pediatr"},{"key":"R77-20230911","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.psym.2017.03.009","article-title":"Use of transdermal selegiline in pregnancy and lactation: a case report","volume":"58","author":"Bauer","year":"2017","journal-title":"Psychosomatics"},{"key":"R78-20230911","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3390\/ph6101221","article-title":"The use of central nervous system active drugs during pregnancy","volume":"6","author":"K\u00e4ll\u00e9n","year":"2013","journal-title":"Pharmaceuticals"},{"key":"R79-20230911","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jpeds.2012.03.003","article-title":"Neonatal benzodiazepines exposure during breastfeeding","volume":"161","author":"Kelly","year":"2012","journal-title":"J Pediatr"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003081-201809000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T08:14:47Z","timestamp":1694420087000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003081-201809000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000365","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}